PMC:7594251 / 128220-128334 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7594251","sourcedb":"PMC","sourceid":"7594251","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7594251","text":"Drug (Company) Target Original Fragment(s) * Advanced Molecule and Progress in Clinical Trials Techniques Used","divisions":[{"label":"th","span":{"begin":0,"end":14}},{"label":"th","span":{"begin":16,"end":22}},{"label":"th","span":{"begin":24,"end":46}},{"label":"th","span":{"begin":48,"end":97}}],"tracks":[{"project":"LitCovid-sentences","denotations":[{"id":"T896","span":{"begin":0,"end":114},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T896","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-sentences","color":"#9394ec","default":true}]}]}}